Bank Of America Corp Amicus Therapeutics, Inc. Call Options Transaction History

Bank Of America Corp

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $171,325 - $305,800	27,500 Added 220.0%	40,000 $429,000
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $39,450 - $62,400	5,000 Added 66.67%	12,500 $118,000
Q4 2021 Feb 08, 2022	BUY	$9.82 - $12.44 $73,650 - $93,300	7,500 New	7,500 $87,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.